↓ Skip to main content

Hospital pharmacist's roles and responsibilities with CAR-T medicines

Overview of attention for article published in Farmacia Hospitalaria, January 2020
Altmetric Badge

Mentioned by

twitter
1 X user

Citations

dimensions_citation
12 Dimensions

Readers on

mendeley
40 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Hospital pharmacist's roles and responsibilities with CAR-T medicines
Published in
Farmacia Hospitalaria, January 2020
DOI 10.7399/fh.11333
Pubmed ID
Authors

María Estela Moreno-Martínez, Joan Vinent-Genestar, Carmen Muñoz-Sánchez, María Josep Carreras-Soler

Abstract

The development and commercialization of cell therapy drugs with  chimeric antigen receptor T cells (CAR-T) represent a new challenge for  Spain's hospital pharmacy. The aim of this article is to review the key  aspects of these medicines and to describe the oncohematological  pharmacist's role within the multidisciplinary clinical team. This includes  the different phases in the transversal process that involves a therapy  with CAR-T medicines, ranging from indication to short and long term  follow-up of patients treated with this type of therapy, and emphasizing  on the management of its main adverse effects. CAR-T therapy offers  the hospital pharmacist the opportunity to work closely with the rest of  the clinical professionals involved in the process, allowing their  contribution to the development of procedures, clinical practice  guidelines of global approach, and establishing starting points when  facing future therapies of similar complexity -and even improving previously established basic processes-.

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 40 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 40 100%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 4 10%
Lecturer 2 5%
Other 2 5%
Student > Ph. D. Student 2 5%
Student > Master 2 5%
Other 3 8%
Unknown 25 63%
Readers by discipline Count As %
Pharmacology, Toxicology and Pharmaceutical Science 6 15%
Chemistry 3 8%
Medicine and Dentistry 2 5%
Physics and Astronomy 1 3%
Biochemistry, Genetics and Molecular Biology 1 3%
Other 2 5%
Unknown 25 63%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 07 January 2020.
All research outputs
#22,771,990
of 25,387,668 outputs
Outputs from Farmacia Hospitalaria
#306
of 368 outputs
Outputs of similar age
#402,956
of 473,316 outputs
Outputs of similar age from Farmacia Hospitalaria
#5
of 5 outputs
Altmetric has tracked 25,387,668 research outputs across all sources so far. This one is in the 1st percentile – i.e., 1% of other outputs scored the same or lower than it.
So far Altmetric has tracked 368 research outputs from this source. They receive a mean Attention Score of 2.7. This one is in the 1st percentile – i.e., 1% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 473,316 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 1st percentile – i.e., 1% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 5 others from the same source and published within six weeks on either side of this one.